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Campylobacteriosis is a zoonosis that can be transmitted directly or indirectly between animals and humans 
leading to intestinal infections. Eating undercooked chicken, or ready-to-eat foods that have been in contact 
with raw chicken, is the most common source of the infection (20-30%). There are currently 25 species in the 
Campylobacter genus;  however  Campylobacter jejuni  and  C. coli  are  the  two  principal causes  of  human 
gastroenteritis worldwide. Though death from campylobacteriosis is rare, risk of complications in risk groups 
is high namely in the young and elderly, and those with concurrent chronic disease and immunocompromised 
status. Campylobacteriosis affects the digestive system, causing diarrhoea, abdominal pain, malaise, fever, 
nausea and vomiting. The costs based on the incidence, prevention and control of campylobacteriosis are high 
with  critical  impacts  on  surveillance  programmes  and  hence  the  costs  and  benefits  must  be  carefully 
considered. Bacteriophages have been discussed worldwide as a therapeutic tool to control and prevent 
Campylobacter. Another promising strategy is the addition of lactic acid bacteria and/or bacteriocins in the 
feed to mnimise/control Campylobacter in poultry. Antibiotic treatment is a control strategy but several 
authors have been describing the occurrence of multidrug resistance profiles among Campylobacter strains. 
There is now a strong movement against the use of antibiotics in food production. In addition, several “Model 
Food  Codes”  (proper  sanitation  and  cooking  procedures)  are  described  in  order  to  prevent  cross-
contamination, which can subsequently decrease the risk of Campylobacter infection. 
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1. Campylobacter and Campylobacteriosis – an Overview 
 
Campylobacter genus typically comprises of microaerophilic spiral-shaped Gram-negative cells. 
Growth under aerobic and anaerobic conditions has also been reported; they require relatively high 
temperatures (Silva et al., 2011). Campylobacter is the organism responsible for campylobacteriosis 
in humans. About 200,000 human cases are reported every year and this disease is still the most 
frequently reported foodborne illness in the Europe Union (EU). Recently, European Food Safety 
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Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC) reported that for 
the first time in five years, human cases of campylobacteriosis decreased slightly in 2012, however, 
it is premature to suggest that this is the beginning of a downward trend (EFSA, 2014a). Although 
the number of campylobacteriosis cases is high, the number of fatalities is low (0.03%; EFSA, 
2014a). 
 
In 2013, the Foodborne Diseases Active Surveillance Network (FoodNet) of the Centers for Disease 
Control and Prevention (CDC) in the USA, estimated an incidence of 1,382 cases of 
campylobacteriosis per 100,000 population in the USA and 1,010 hospitalizations represented by 
12 deaths; in addition, it is estimated that for every Campylobacter case reported, there are 30 cases 
not diagnosed (Crim et al., 2014; http://www.cdc.gov/foodnet/). 
 
The incubation period of campylobacteriosis is typically 2 to 4 days but can range from one to 10 
days (Heymann, 2008). Studies have shown that several Campylobacter spp. have the ability to 
attach to and invade human intestinal epithelial cells and macrophages, damage intestinal barrier 
integrity, secrete toxins and strategically evade host immune responses (Man, 2011). Common 
symptoms include diarrhoea (frequently bloody), abdominal pain, fever, and occasionally nausea 
and vomiting. Severe illness might occur, sometimes fatal, especially in young children, frail or 
elderly people, and others with weakened immune systems, including dehydration, bloodstream 
infection,   and   symptoms   mimicking   acute   appendicitis   or   ulcerative   colitis (Coker,   2002; 
Pacanowski et al., 2008). Guillain-Barré syndrome is a well-established post-infectious 
complication of campylobacteriosis resulting in a polyradiculoneuropathy with a variable clinical 
presentation (Fokke et al., 2014). The infective dose is reportedly low, with 500 organisms required 
to cause illness (Silva et al., 2011).  
 
Campylobacteriosis remains largely under-reported; early and specific diagnosis is important to 
ensure a favorable outcome regarding this foodborne disease. Antibiotic treatment is 
controversial, and only has a benefit on the duration of symptoms; some simple hygienic food 
handling practices can prevent Campylobacter infections (Sarkar et al., 2014). The most commonly 
isolated agents in human infections are C. coli and C. jejuni followed by C. lari; these species are 
carried normally in the intestinal tracts of many domestic and wild animals (Silva et al., 2011; EFSA, 
2014a). In fact, most human campylobacteriosis infections are due to C. jejuni, 90%, with a few due 
to C. coli, 10% (Wilson et al., 2008).  Other species of Campylobacter have been recognized as 
emerging human and animal pathogens e.g. C. concisus, C. upsaliensis and C. ureolyticus (Ma, 2011). 
 
2. Occurrence of Campylobacter 
 
Eating contaminated foods (e.g. undercooked chicken and foods contaminated by raw chicken), 
drinking  contaminated  water  or  raw  (unpasteurized)  milk,  and  having  contact  with  animals, 
particularly farm animals such as cows and chickens, as well as domestic cats and dogs, are the 
major modes of transmission of Campylobacter spp. In addition, Campylobacter spp. can be 
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2.1. Campylobacter in food 
 
Campylobacter spp. are often found in contaminated food products representing a risk of 
zoonotic transmission  to  humans;  consumption  of  contaminated,  unpasteurized  animal  milk  
and  milk products, undercooked poultry and contaminated drinking water is well recognized as 
a vehicle of infection (EFSA, 2014b; Sarkar et al., 2014). Poultry are natural and asymptomatic 
carriers of C. jejuni and C. coli responsible for up to 80% of the human Campylobacter infections 
(Wagenaar et al., 2013). According to these authors, it is estimated that in the EU, 30% of the 
human infections are associated with consumption and preparation of poultry meat. 
Campylobacter spp. can be present in various foodstuffs including meat, raw milk and dairy 
products and less frequently in fish and fishery products, mussels and fresh vegetables (EFSA, 
2014a).  
 
According to Andrzejewska et al. (2015), the occurrence of Campylobacter spp. in poultry meat 
from Northern Poland is 41.6% with higher incidence of C. jejuni. In Estonia, the prevalence and 
counts of Campylobacter spp. in poultry meat at retail level was shown to be 20.8% and 3.20 log10 
CFU/g (mean number of campylobacters in fresh broiler chicken meat) (Mäesaara et al., 2014). In 
Latvia the occurrence of Campylobacter spp. in broiler chicken production at slaughterhouse and 
retail  level  was  determined  and  it  was  reported  that  92.5%,  60.8%  and  56.3%  of  the  pooled 
intestine samples, the neck skin samples and of carcasses were positive for Campylobacter spp., 
respectively  (Kovalenkoa  et  al.,  2014).  According  to  these  authors,  a  seasonal  variation  was 
observed  in  proportions  of Campylobacter  positive  samples,  with  a  seasonal  peak  in  summer 
months. A total of 471 duck and goose intestinal contents were analysed by Jamalia and 
collaborators (Jamalia et al., 2015); 39.2% of duck and 26.1% of goose samples were positive for 
Campylobacter spp. The isolates were mainly C. jejuni (85.7%) and C. coli (14.3%). Fresh or 
minimally processed vegetables can be contaminated before harvest or throughout handling. The 
survival of C. jejuni strains on spinach under different conditions was evaluated (Guévremont et 
al., 2015). Strains of this species from different animal or environmental origins were able to 
survive on spinach; this survival was dependent on the storage parameters and bacterial strain. 
According to these authors, fresh spinach with a significant contamination can represent a threat to 
human health. 
 
2.2. Campylobacter in animals 
  
Poultry and poultry products are considered to be the largest contributors of human 
Campylobacter infection, 50-70% estimated. Poultry includes broilers, laying hens, turkeys, ducks, 
and ostriches (Sharon et al., 2013). Contact with contaminated poultry, livestock or household 
pets, especially puppies, can also cause the disease (Sarkar et al., 2014). In fact, Campylobacter 
spp. colonize a wide range of hosts including pets, farm animals and wild animals. Primarily, 
Campylobacter is found in broiler flocks (reported prevalence varies between the EU member 
states, but high prevalence (63.4%) and extremely high (83.6%) have already been reported) but 
also in pigs, cattle, goats, sheep and pets (EFSA, 2014a). Little information is available concerning 
the role of Campylobacter spp. in large game species; Campylobacter spp. strains associated with 
human campylobacteriosis were infrequently detected in 33 hunting estates during two hunting 
seasons, indicating a limited zoonotic risk in the studied area (Díaz-Sánchez et al., 2013). The 
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presence of Campylobacter spp. was evaluated in faeces (N = 574) and carcasses (N = 585) 
sampled from red deer (N = 295), wild boar (N = 333) and other ungulates (fallow deer, mouflon) 
(N = 9).  
 
The prevalence of Campylobacter spp. in fresh and dried wild-bird fecal samples was estimated 
by Abdollahpour et al. (2015); samples   were   collected   from   5   publicly   accessible   children's 
playgrounds in Mashhad, Iran. Seventy and a fifty percent of the faeces were positive for 
Campylobacter spp.; the occurrence was higher in fresh faecal samples. This study emphasizes 
the importance of wild bird species as a reservoir for Campylobacter spp. 
 
3. Outbreaks of Campylobacteriosis 
 
Despite the high numbers of campylobacteriosis cases, outbreaks caused by this agent are 
uncommon compared with sporadic cases (Little et al., 2010; Taylor et al., 2013; Revez et al., 
2014). The outbreaks have historically differed from sporadic cases inseasonality and 
contamination source. According to Taylor and his collaborators (2013), in the USA, from 1997 to 
2008, 262 outbreaks were reported, with 9,135 illnesses, 159 hospitalizations, and three deaths. 
According to these authors, poultry and dairy products are the most common vehicles identified 
for outbreaks, namely 11 and 29%, respectively. Historically, few foods have been recalled due to 
the presence of Campylobacter spp. (Table 1), whereas contaminated drinking water and 
unpasteurized raw milk have occasionally been recalled due to Campylobacter contamination 
(Taylor et al., 2013; Revez et al., 2014). During 1998–2008, CDC received reports of 13,405 
foodborne disease outbreaks, eight pathogens caused 89% of the 5,059 confirmed, single-etiology 
outbreaks, 2% caused by C. jejuni (Gould et al., 2013). In the UK, from 1992 to 2009, 114 
foodborne outbreaks of campylobacteriosis were reported to the Health Protection Agency; 64% 
occurred in food service establishments. Poultry meat was the most commonly reported vehicle 
of infection (38%) (Little et al., 2010). According to this study, since 2007, the number of 
outbreaks of campylobacteriosis linked to consumption of poultry liver pâté in England  and  
Wales  significantly  increased  (from  12%  to  74%)  with  a  higher  frequency  in December. 
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Unicomb et al. (2009) studied the frequency of Campylobacter outbreaks in Australia from 
January 2001 to December 2006; 33 Campylobacter outbreaks were reported, affecting 457 
persons. Transmission was predominantly foodborne or suspected foodborne (82%), 30% of the 
foodborne outbreaks were attributed to food prepared or eaten at institutions; 15% at aged care 
facilities and 11% at school camps. Poultry (chicken or duck), waterborne, unpasteurized milk and 
salads were associated with the reported outbreaks.  According to these authors, outbreaks 
continue to constitute a very small proportion of notifications since improved recognition through 
subtyping is required.  
 
Parry et al. (2012) reported an outbreak of campylobacteriosis associated with chicken liver pâté 
at a   surprise   birthday   party;   outbreaks   of   this   kind   may   be   greatly   underestimated   
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since Campylobacter isolates are not routinely subtyped and the identification of outbreaks is 
largely restricted to temporal or geographical associations or reliance on medical notifications 
identifying common events. According to (EFSA, 2014a), half of the Campylobacter outbreaks 
have been related with broiler meat and raw milk. In addition, from 2008 to 2012 a clear 
seasonal trend was observed in Europe. In 2012, 31 deaths due to campylobacteriosis were 
reported (in 14 member states); 20 of those deaths were in the United Kingdom. Campylobacter 
jejuni and C. coli were responsible for 81.1 and 6.2% of the cases, respectively. 
Globally, defining the scope of a given outbreak, identifying the source of the strains and tracing 
the route by which the bacteria infect the humans are crucial parameters that should be 
considered. 
 
4. Antibiotic Resistance – the Need for Alternative Controls 
 
Historically antibiotics have been used in livestock farming both for the treatment of infections and 
as growth promoters. However the practice of administering growth promoters containing 
antimicrobials has been gradually banned in Europe (2013).  
 
The frequent use of antibiotics in the veterinary field, has been contributing to the increased 
trend in the resistance of Campylobacter strains (and also in other foodborne pathogens) isolated 
from man and poultry, especially to fluoroquinolones and macrolides (Endtz et al., 1991; 
Nachamkin et al., 2002; Wieczorek and Osek, 2013). In fact, resistant and particularly multi-
resistant Campylobacter strains are being alarmingly spread, representing an increasing 
phenomenon that demands enforced interventions at multidisciplinary levels and is one of the 
challenges of campylobacteriosis control, worldwide  (Wimalarathna et al., 2013; Carmelo et 
al., 2013; EFSA, 2014b). In the European Union, antimicrobial resistance is commonly detected 
in Campylobacter isolated from human cases as well as from food-producing animals and food 
(EFSA, 2014b). According to the last summary report disseminated by EFSA (2014b), a high 
resistance level to ampicillin, ciprofloxacin, nalidixic acid and tetracycline among Campylobacter 
isolates from human cases was reported by the member states, while resistance to erythromycin 
was low to moderate. The resistance trend for C.  jejuni isolates  was for  ciprofloxacin  (54.1%) 
and  for  nalidixic  acid 53.3%. Among C. coli isolates, 69% were reported resistant to nalidixic 
acid and ciprofloxacin, followed by tetracyclines 49.7% and ampicillin 36.0%. Concerning 
isolates of C. jejuni and C. coli, the  levels  of  resistance  to  erythromycin  is  overall  low  and  
moderately  high,  respectively.  In addition, one in six human C. coli isolates were resistant to 
both erythromycin and ciprofloxacin. These   two   antibiotics   are   commonly   administrated   for   
treatment   of   campylobacteriosis emphasizing the problem related with combined resistance (co-
resistance) to critically important antimicrobials (EFSA, 2014b). However, according to EFSA, co-
resistance to critically important antimicrobials remains low (EFSA, 2014b). 
 
Concerning Campylobacter isolates from food samples, namely fowl, broiler meat, pigs and cattle, 
high  to  extremely  high  resistance  to  ciprofloxacin,  nalidixic  acid  and  tetracyclines  and  
low resistance levels for erythromycin and gentamicin were recorded (EFSA, 2014b): 59.5%, 
57.9% and 47.5%  of  strains  of  C. jejuni  isolated  from  meat  and  broilers,  were  resistant  to  
ciprofloxacin, nalidixic acid and tetracycline, respectively. For C. coli, the percentages of strains 
resistant to these three  antibiotics  was  of  82.7%,  81%  and  57.3%,  respectively  (EFSA,  
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2014b).  Overall, C. coli presented a higher resistance trend compared to C. jejuni, for both human 
and food strains. Griggs et al. (2005) reported quinolone-resistant Campylobacter strains in 
commercial chicken flocks that were treated with veterinary fluoroquinolone; 53% of the C. 
jejuni and 82% of C. coli were   ciprofloxacin   resistant.   In   addition,   these   authors   reported   
that   quinolone-resistant Campylobacter strains  were  present  in  the  faeces  of  some  flocks  up  
to  the  point  of  slaughter, thereby   presenting   a   potential   public   health   problem.   According 
to Hart et al. (2004), Campylobacter strains isolated from pigs are mainly ciprofloxacin-susceptible, 
since in Australia the application   of   fluoroquinolones   in   animal   production   is   prohibited.   A   
significantly   higher prevalence of Campylobacter isolates resistant to ciprofloxacin was reported 
by Maćkiwa et al. (2012), 97.9%. Moreover, 7.0% of the isolates were found to be resistant to at 
least three unrelated antibiotics. According to Abay et al. (2014), erythromycin, amoxicillin, 
clavulanic acid and gentamicin are recommended  for  the  treatment  of  Campylobacteriosis  in  
humans  since  most  of  the  C. jejuni isolated from poultry and humans in T.urkey were sensitive 
to these antibiotics. Wimalarathna et al. (2013) reported that 38.02% of C. jejuni and C. coli 
isolates were resistant to tetracycline and 22.26% to quinolones.  Concerning erythromycin and 
chloramphenicol, low resistance levels were observed, 4.59% and 2.59%, respectively. 
 
Jamalia et al. (2015) reported that Campylobacter isolates collected from ducks and geese were 
resistance to ciprofloxacin, tetracycline and nalidixic acid; among those strains, 60.2% were 
multidrug resistant.  
 
In Portugal, a high resistance rate was reported for quinolones (n = 196 Campylobacter 
strains; 100% to nalidixic acid and > 90% to ciprofloxacin) and, in general, resistance was more 
common among C. coli, especially for erythromycin (40.2% vs. 6.7%; Duarte et al., 2014). 
According to these authors, most isolates (86%) were resistant to multiple antimicrobial families. 
 




The widespread acquisition of antimicrobial resistance among Campylobacter isolates has been a 
matter of concern and the elimination of antibiotics as growth promoters in livestock is being 
actively examined (Ganan et al., 2012). Thereby, new, natural and sustainable strategies have been 
reported in the literature in order to reduce the incidence of this bacterium in the food chain, 
especially in its main host. One particular strategy is the use of bacteriophages, viruses that 
can only lyse targeted bacterial cells (Loc-Carrillo et al., 2011). The specificity of phages to the 
target bacteria is well known; once the phage attaches to the host cell, its DNA is ejected into the 
cell and takes over the host's DNA replication, transcription and translation processes to produce 
progeny phages. On lysis of the producing cells, ‘new’ phages are then capable of infecting other 
target cells nearby. This specificity and effectiveness prevents dysbiosis which means that the 
normal flora is not affected (Guttman et al., 2005). According to García et al. (2008), phages can be 
used to combat pathogens in food at all stages of production in the classic ‘farm-to-fork’ continuum 
in the human food chain. Phages  for  use as  therapeutic or biocontrol agents  on pathogenic  
bacteria such  as Campylobacter, must meet a few criteria namely i) they must be obligatorily lytic 
and therefore only capable of infecting bacterial cells and producing progeny phage without the 
capacity to integrate into the bacterial genome or transduce bacterial genes from one cell to 
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another (Canchaya et al., 2003) and ii) possess physical characteristics that will facilitate their 
survival in the environments to which they will be applied (Loc-Carrillo et al., 2011; Carvalho et al., 
2012b). 
 
In 2005, Wagenaar et al. reported that phage therapy is a promising alternative for reducing 
C. jejuni colonization in broilers, either as a preventive or a therapeutic measure. According to the 
results obtained, these authors suggested that the phage treatment did not prevent the 
colonization of  the caecum,  but may delay  it;  an  initial  reduction  of  Campylobacter  by  2  
log10  CFU/g  was observed and one week after the numbers reached out at approximately 1 log10 
compared with the control (no phage administered to the chicks). In the study conducted by Loc 
Carrillo et al. (2011), chickens were treated with two Campylobacter phages, CP8 and CP34. The 
results varied within the tested phage and according to the dose administered to the chicken; CP8 
was shown to have the higher efficacy for reducing Campylobacter in the chicken caecum (> 5 
log10 CFU/g). Later, El- Shibiny et al. (2009) reported that a single 107 or 109 PFU (plaque 
forming units) dose of CP220 resulted in a 2 log10 CFU/g reduction in Campylobacter counts that 
colonized chickens; after treatment, only 2% of the recovered Campylobacter displayed resistance 
to CP220. More recently, Carvalho et al. (2010) studied the efficacy of a phage cocktail composed 
of three phages for the control of poultry infected with C. coli and C. jejuni; the phage cocktail 
was able to reduce by approximately 2 log10 CFU/g the titre of both C. coli and C. jejuni in 
faeces of colonized chickens.  
 
These authors also tested the administration of phages in feed to Campylobacter-infected 
chicks and  concluded  that  administering  phages  to  poultry  via  the  food  could  be  successful  
on  a commercial scale (faster reduction). Campylobacter phages have been isolated from several 
sources namely sewage, pig and poultry manure, abattoir effluents, broiler chickens and retail 
poultry. After the isolating step, phages have been characterized and special attention has been 
given to the lytic spectrum of each phage or a given mixture of phages. Globally, the sensitivity to 
individual bacteriophages varies according to the strain and specie (Bigwood et al., 2008; 
Carvalho et al., 2009; El-Shibiny et al., 2009; Loc-Carrillo et al., 2011; Carvalho et al., 2012b; Owens 
et al., 2013). To date, six Campylobacter phage sequences have been published and are available 
in EMBL and GeneBank (Timms et al., 2010; Kropinski et al., 2011; Carvalho et al., 2012a; 
Hammerl et al., 2012). The development of phage-resistant mutants has already been reported as 
potentially a contra- indication in the application of phages [42]; however further research is 
still needed to answer which type of resistance is actually relevant for phage therapy and other 
phage applications (Loc- Carrillo et al., 2011). Phage-based products against Campylobacter are not 
on the market but a few companies have publically declared interest in developing such products 
including Intralytix, GangaGen and Micreos (Loc-Carrillo et al., 2011). 
 
5.2. Probiotics and bacteriocins 
 
Alternative practices to biocontrol Campylobacter spp. in broiler feed are currently being 
investigated namely probiotics (Gaggia et al., 2010) and bacteriocins (Svetoch and Stern, 
2010). However  limited  information  is  available  regarding  their  effects  in  poultry  namely  in  
poultry nutrition and/or microbiology (Józefiak and Sip, 2013). Bacteriocins have either 
bactericidal or bacteriostatic activity and are known as antimicrobials that do not disturb the 
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global ecosystem. Lactic acid bacteria and bacteriocins are generally recognized as safe (GRAS; so 
far there has been no information about negative effects on animals or humans) and their 
industrial interest has been increasing.  However  two  limitations  are  recognized:  i)  the  
spectrum  of  activity  of  most  LAB bacteriocins is rather narrow and may not inhibit the variety 
of microorganisms found in foods; ii) less  activity  against  Gram-negative  bacteria  and  iii)  
bacteriocin  resistance.  Strains  producing bacteriocins  are  commonly  spread  among  genera  
of  Lactobacillus,  Lactococcus,  Pediococcus, Carnobacterium,  Enterococcus,  Escherichia,  Bacillus,  
Paenibacillus,  Staphylococcus,  Pseudomonas, Clostridium,  and others  (Svetoch  and Stern,  2010).  
Bacteriocins are divided into 3 classes and classes I and II are the best studied and have practical 
application. Cole and his collaborators (Cole et al., 2006) reported that bacteriocins produced by 
Bacillus circulans and Paenibacillus polymyxa reduce caecal Campylobacter colonization in broiler 
chickens infected with C. jejuni. Bacteriocins, with antimicrobial activity against C. jejuni, were 
reported to be present in broiler chicken excreta (Nazef et al., 2008; Belguesmia et al., 2011).  
 
In 2008, Stern et al. (2008) studied the effect of adding probiotic strains to chicken feed as a 
prophylactic probiotic treatment. These authors reported that probiotic strains were effectively 
reduced C. jejuni colonization only when very low challenge levels of C. jejuni were used. Two of 
those probiotic strains were selected, Lactobacillus salivarius NRRL B-30514 and Paenibacillus 
polymyxa NRRL B-30509, and further studied for efficacy in reducing C. jejuni in chickens. 
Purified bacteriocins/kg feed were fed therapeutically to chickens and colonization by C. jejuni 
was reduced by at least one million-fold. However, treatments with viable probiotic bacterial 
cultures were ineffective in reducing C. jejuni in chickens. 
 
Bacteriocin treatments can reduce poultry colonization of Campylobacter from > 108 cfu/g of 
caecal materials  to  non-detectable  or  very  low  levels  in  treated  birds  (Svetoch  and  Stern,  
2010). Connerton et al. (2011) also verified that feeding broilers with bacteriocins reduced 
Campylobacter to non-detectable levels. According to the work reported by Messaoudi et al. 
(2012), L. salivarius  SMXD51,  previously isolated from chicken caeca, produces a component that 
inhibits the growth of C. jejuni (bacteriocin SMXD51) that has potential to reduce Campylobacter in 
poultry prior to processing. 
 
5.3. Other alternatives for the control of Campylobacter 
 
Natural products from plants present good alternatives to be used in foods or as therapeutic 
agents in order to prevent/control Campylobacter spp. (2011). These authors tested 28 edible or 
medicinal plant species for their bactericidal effects on the growth of C. jejuni and C. coli.  Acacia 
farnesiana, Artemisia ludoviciana, Opuntia ficus-indica, and Cynara scolymus extracts were the 
most effective against Campylobacter; adherence and cytotoxic activity of the bacteria to host 
mucosal surfaces was decreased by these extracts. In fact, plants are potential candidates for the 
control of Campylobacter contamination in foods, the treatment of the diseases associated with 
this microorganism, and as feed supplements to reduce on-farm prevalence of  Campylobacter 
(Castillo et al., 2011).  
 
The anti-Campylobacter effect of natural phenolic compounds extracted from plants has also 
been described by Klancˇnik and his collaborators, 2012. These authors emphasized the high 
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potential of these agents. Salaheen and his collaborators (2014) tested the effect of the bioactive 
components from blueberry and blackberry pomaces on C. jejuni growth and pathogenicity. 
Blackberry and blueberry pomace extracts significantly reduced the growth of C. jejuni by 
altering some of the physicochemical properties such as the cell surface hydrophobicity and 
auto-aggregation of this bacterial pathogen. In addition, swimming and swarming motility of C. 
jejuni were significantly reduced as well as the expression of the virulence genes and their 
interactions with host cultured cells.  
 
Solis de los Santos et al. (2009) reported that therapeutic supplementation of caprylic acid in the 
feed  can  effectively  decrease  Campylobacter in  market-aged  chickens  and  may  be  a  
potential treatment for decreasing pathogen carriage in poultry. Recently, Arsi et al. (2014) 
reported the efficacy of natural plant extracts such as thymol and carvacrol against 
Campylobacter colonization in broiler chickens. They observed that feed supplementation with 
these compounds reduced Campylobacter colonization in chickens. 
 
The utilization of natural products in the control/prevention of Campylobacter should be in 
agreement with what can be legally premised in animal husbandry. Vaccination  of  chickens  
against  Campylobacter  has  also  been  reported,  however  a  commercial vaccine  against  
Campylobacter  has  not  yet  been  developed  (de  Zoete  et  al.,  2007;  Jagusztyn- Krynicka et al., 
2009; Zeng et al., 2010). Zeng et al. (2010) developed a novel vaccine against C. jejuni - CmeC 
Subunit Vaccine. According to these authors, this approach can reduce the frequency of in vivo 
emergence of antibiotic resistant C. jejuni. 
 
6. Preventing Campylobacter and Good Practices 
 
To prevent Campylobacter infections, it is important to follow basic food hygiene practices when 
preparing food. In fact, improving culinary and catering practices are important procedures 
f o r  2009; Zeng et al., 2010). Zeng et al. (2010) developed a novel vaccine against C. jejuni - 
CmeC Subunit Vaccine reducing exposure to Campylobacter-contaminated products (Newell et 
al., 2011). According to these authors, from 1992 to 2009, 114 general foodborne outbreaks of 
campylobacteriosis were reported to the Health Protection Agency, most occurring in food service 
establishments (64%). Some food handling practices that can prevent Campylobacter infections 
include the following: 
 
- Cook all types of poultry products properly; all poultry should be cooked to reach a minimum 
internal temperature of 74 ºC; 
- Wash hands frequently when preparing food especially after handling raw foods from 
animal origin; 
- Prevent cross contamination i.e. using separate cutting boards for foods of animal origin and 
other foods and by thoroughly cleaning all cutting boards, countertops, and utensils with soap and 
hot water after preparing raw food of animal origin; 
- Do not drink unpasteurized milk or untreated surface water; 
-  Make  sure  that  people  with  diarrhea,  especially  children,  wash  their  hands  carefully  and 
frequently to reduce the risk of spreading the infection; 
- Wash hands with soap and hot water after contact with pet faeces. 
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On the other hand, to prevent Campylobacter from being transmitted to a poultry flock (primary 
production), biosecurity implementations are required, namely use of modern housing that is 
well maintained and with limited access, boot dips, and fly screens (Newell et al., 2011). These 
authors also reported that complimentary non-biosecurity measures are relevant to reduce the 
risk of flock infection such us thoroughness of cleaning and disinfecting the poultry house between 
flocks. Some of these measures are concerned with appropriately treated water for drinking, 
reducing slaughter age and discontinuing thinning (Zeng et al., 2010). According to Guerin et al. 
(2010), chilling, washing, defeathering, scalding and evisceration have shown a limited effect at 
reducing the presence of Campylobacter. Post-slaughter irradiation or cooking on an industrial 
scale can reduce the risk by 100%. Freezing the carcasses for 2–3 weeks can reduce the risk by > 
90%, whereas freezing for 2–3 days will reduce the risk between 50 and 90%; these results are 
similar to carcass decontamination using hot water, lactic acid, acidified sodium chlorite or 
trisodium phosphate (EFSA, 2011; Meredith et al., 2013). 
 
7. The Cost of Campylobacteriosis 
 
EFSA claims that the cost of campylobacteriosis to public health systems and to lost productivity in 
the EU is estimated to be around EUR 2.4 billion a year (EFSA, 2014a). In the United States, 
Campylobacter is reported to be the third most prevalent bacterial pathogen with an estimated 
annual cost of illness to be $1.7 billion (Jensen et al., 2015). In Europe campylobacteriosis is 
the most   common   foodborne   bacterial   illness   and   estimates   of   the   true   incidence   rate   
for Campylobacter-associated infections is 9.2 million, with a total annual cost of €2.4 billion 
(Meredith et al., 2013). 
 
According to Jensen et al. (2015), using a system-wide policy approach to reduce the risk of 
campylobacteriosis can be more cost-effective than a policy focusing purely on farm-level 
interventions. In addition, according to these authors, allowing for chemical decontamination 
methods may enhance cost-effectiveness of intervention strategies further. Wagenaar and 
collaborators (2013) commented that interventions in the poultry meat production chain have not 
been effectively introduced and a multilevel approach should be followed, aiming at reducing the 




The actual incidence rate of gastroenteritis due to Campylobacter spp. is poorly known and 
frequently under-reported, and several approaches are being used to estimate it. Worldwide, 
Campylobacter is considered to be the most frequently occurring bacterial agent of 
gastroenteritis. In order to control/reduce this contaminant, several promising biocontrol 
approaches can be considered, namely the addition of LAB such as probiotics, bacteriocins and/or 
bacteriophages. These suggestions are in alignment with the EFSA report and should be 
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